Interstitial HDR-Brachytherapy of unresectable pancreatic carcinoma by 3-D-CT-planning in combination with external beam radiation and chemotherapy. Methodology and clinical results;3D-CT-geplante interstitielle HDR-Brachytherapie + perkutane bestrahlung und chemotherapie bei inoperablen pankreaskarzinomen: Methodik und klinische ergebnisse

Strahlentherapie und Onkologie

Volumn 174, Issue 3, 1998, Pages 133-141

  Pfreundner, L ^a,d   Baier, K ^a   Schwab, F ^a   Willner, J ^a   Bratengeier, K ^a   Flentje, M ^a   Feustel, H ^b   Fuchs, K H ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Tropenmedizinische Abteilung   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d Klin/Poliklin Haut /G   (Germany)

Author keywords

3D CT planning; Brachytherapy; Pancreatic carcinoma

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRIDIUM 192;

ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; FEMALE; HUMAN; INTERSTITIAL RADIATION; MALE; PANCREAS CANCER; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0031913063     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038496     Document Type: Article

References (47)

1. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 1981;7:863-8.
2. Ahlgren JD. Chemotherapy for pankreatic carcinoma. Cancer 1996;78: 654-63.
3. Butowski RM, Schacter LP, Groppe CW, Hewlett JS, Weick JK, Livingston RB. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and strepozotocin (FAM-S) in pancreatic carcinoma. Cancer 1982;50: 197-200.
4. Connolly MM, Dawson PJ, Path FRC, Michelassi F, Moossa AR, Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366-70.
5. Copping J, Willix R, Kraft R. Palliative chemical splanchniectomy. Arch Surg 1978;113:509-11.
6. Dobelbower RR Jr, Howard J, Bagne J, Eltaki F, Merrick III H. Treatment of cancer of the pancreas by precision high dose (PHD) external photon beam and intraoperative electron beam therapy (IOEBT). Int J Radiat Oncol Biol Phys 1989;16:205-9.
7. Dobelbower RR Jr, Konski AA, Merrick III HW, Bronn DG, Schifeling D, Kamen C. Intraoperative electron beam radiation therapy (IOEBRT) for carcinoma of the exocrine pancreas. Int J Radiat Oncol Biol Phys 1991;20:113-9.
8. Dobelbower RR Jr, Merrick III HW, Ahuja RK, Skeel RT. 125 I interstitial implant, precision high-dose external beam therapy, and 5 FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree. Cancer 1986;58:2185-95.
9. Dutreix A, Marinello G. The Paris system. In: Pierquin B, Wilson J-F, Chassagne D. Modern brachytherapy. New York-Paris: Masson, 1987: 25-42.
10. Evans DB, Termuhlen PM, Byrd DR, Ames FC Dchran TG, Rich TA. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 1993;218:34-60.
11. Foo ML, Gunderson LL, Nargorney DM et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-9.
12. Fortner JG, D'Angio GJ, Hilaris BS, Arthur K, Murphy JM, Fischer HJ. Iodine-125 implantation for unresectable cancer of the pancreas. Postgrad Med 1970;47:226-30.
13. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-10.
14. Goertz SR, Ali MM, Parker GA. Local management of pancreatic carcinoma: iodine-125 implantation. Clin Oncol 1990;2:22-6.
15. Goldson A. Preliminary clinical experence with intraoperative radiotherapy. J Natl Med Assoc 1978;70:493-5.
16. Gunderson LL, Martin JK, Kvols LT. Intraoperative and external beam irradiation +5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1987;13:319-25.
17. Ishikawa O, Ohhigashi H, Imaoka S, Furikawa H, Sasaki Y, Fujita M. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992;215:231-6.
18. Ishikawa O, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furakawa H. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215-20.
19. Jessup JM, Steele G, Mayer RJ et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128:559-64.
20. Johnson CD, Schwail G, Flechtenmacher J, Trede M. Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg 1993; 80:1177-9.
21. Johnstone PA, Sindelar WF. Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas 1993:8;335-9.
22. Johnstone PA, Sindelar WF. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys 1993;27:831-4.
23. Joyce F, Burcharth F, Holm H, Stroyer I. Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1990;19:1049-52.
24. Kawamura M, Kataoka M, Fujii T et al. Electron beam intraoperative radiation therapy (EBIORT) for localized pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1992;23:751-7.
25. Kinsella TJ, Sindelar WF. Intraoperative radiotherapy for pancreatic carcinoma - experimental and clinical studies. Cancer 1996;78:598-604.
26. Levin DL, Connolly RR, Devesa SS. Demographic characteristics of cancer of the pancreas: mortality, incidence and survival. Cancer 1981;47: 1446-8.
27. Lillemoe KD, Pitt HA, Palliation - surgical and otherwise. Cancer 1996; 78:605-14.
28. Mohiuddin M, Cantor RJ, Biermann W, Weiss SM, Barbot D, Rosato FE. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1988;14:79-84.
29. Muchmore JH, Preslan JE, George WJ. Regional Chemotherapy for moperable pancreatic carcinoma. Cancer 1996;78:664-73.
30. Nishimura A, Nakano M, Otsu H et al. Intraoperative radiotherapy for advanced carcinoma of the pancreas. Cancer 1984;54:2375-84.
31. Nori D, Hilaris B, Halberg F, Peschel R. Pancreatic cancer. In: Interstitial Collaborative Working Group: Interstitial brachytherapy: physical, biological, and clinical considerations. New York: Raven Press, 1990: 157-64.
32. Peretz T, Nori D, Hilaris B et al. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int J Radiat Oncol Biol Phys 1989;17:931-5.
33. Raben A, Mychalczak B, Brennan M et al. Feasibility study of the treatment of primary unresectabte carcinoma of the pancreas with 103 PD brachytherapy. Int J Radiat Oncol Biol Phys 1996;35:351-6.
34. Sarr MG, Cameron JL. Surgical management oof unresectable carcinoma of the pancreas. Surgery 1983;91:123-33.
35. Shibamoto Y, Manabe T, Baba N et al. High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 1990;19:605-11.
36. Shipley WU, Wood WC, Tepper JE. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg 1984;200:289-95.
37. Sindelar WF, Kinsella TJ, Mayer RJ. Cancer of the Pancreas. In: De Vita VT, Hellman S, Rosenberg SA. (eds.): Principles and practice of oncology, 2nd edn, Philadelphia: Lippincott, 1985:722-6.
38. Staley CA, Lee JE, Cleary KR et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-24.
39. Tepper J, Noyes D, Krall J et al. Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Int J Radiat Oncol Biol Phys 1991;21:1145-9.
40. Tepper JE, Shipley WU, Warshaw AL. The role of misonidazole combined with intraoperative radiotherapy in the treatment of pancreatic carcinoma. J Clin Oncol 1987;5:579-84.
41. Thomas PR. Radiotherapy for carcinoma of the pancreas. Semin Oncol 1996;23:213-9.
42. Ulmer Forschergruppe Onkologie Gastrointestinaler Tumoren (U-FOGT). Palliative Radiochemotherapie beim primär inoperablen Pankreaskarzinom: Intraarterielle Chemotherapie + Radiotherapie alternierend/kontinuierlich. Studienprotokoll.
43. Watanapa P, Williamson RCN. Surgical pallation for pancreatic cancer: developments during the past two decades. Br J Surg 1992;79:8-20.
44. Whittington R, Solin L, Mohiuddin M et al. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 1984;54:1991-8.
45. Willich N, Teichmann R, Kommel K et al. Intraoperative Elektronenbestrahlung (IORT) maligner Pankreastumoren - erste Großhaderner Erfahrungen. Strahlenther Onkol 1988;164:187-94.
46. Yeung RS, Weese JL, Hoffman JP et al. Neoadjavant chemoradiation in pancreatic and duodenal carcinoma. Cancer 1993;72:2124-33.
47. Zerbi A, Fossati V, Parolini D et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994; 73:2930-35.